Diclofenac - XanodyneAlternative Names: XP 21B
Latest Information Update: 03 Aug 2015
At a glance
- Originator Xanodyne Pharmaceuticals
- Class Antipyretics; Antirheumatics; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Phenylacetates; Small molecules
- Mechanism of Action Cyclooxygenase inhibitors; Prostaglandin synthase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Discontinued Acute pain
Most Recent Events
- 17 Feb 2011 Phase-II clinical trials in Acute pain in USA (PO)